Intrinsic InvestorIntrinsic Investor
DashboardStocksAI AnalystAITop IdeasCryptoScreenerWatchlistsPortfolio
SectorsHeatmapETFsMacro
SignalsPROPremium previewTrack recordBacktestDCF builderCompare
Paper tradingTrade historyAlertsConnect broker
Congress tradesEarningsCommunityLearn
Settings
⌘K
Log inSign up free
HomeStocksListsPortfolio
REGN Stock Price & Intrinsic Value | Intrinsic Investor
Back
REGN logo

Regeneron Pharmaceuticals, Inc. (REGN)

Biotechnology
REGN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →
$612.14
+0.11%
Watch Compare
Price · 1 year
Watch+ Add to portfolio
Loading live analysis…
Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS
$41.48
ROE
14.5%
Gross margin
43.9%
Debt/Equity
8.61
Revenue growth
19.0%

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen StocksLearn Intrinsic ValueTrading SignalsCompare Stocks

Explore more

More in Biotechnology →More in Biotechnology →Stocks in US →Stocks on NASDAQ NMS - GLOBAL MARKET →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

AbbVie IncABBVAmgen Inc.AMGNGilead Sciences, Inc.GILDVertex Pharmaceuticals IncorporVRTXAlnylam Pharmaceuticals IncALNYNatera IncNTRA

About Regeneron Pharmaceuticals, Inc.

 

Weekly undervalued picks (like REGN)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.